Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.
about
Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas.H3 K27M mutations are extremely rare in posterior fossa group A ependymoma.Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.Mortality in children with low-grade glioma or glioneuronal tumors: A single-institution study.Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment.Identification of Significant Pathways Induced by PAX5 Haploinsufficiency Based on Protein-Protein Interaction Networks and Cluster Analysis in Raji Cell Line.Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts.Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.Pediatric Low-Grade Gliomas: Next Biologically Driven Steps.Significance of H3K27M mutation with specific histomorphological features and associated molecular alterations in pediatric high-grade glial tumors.Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope?Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology.Molecular Basis of Pediatric Brain Tumors.Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review).Identification and targeting of an FGFR fusion in a pediatric thalamic "central oligodendroglioma".
P2860
Q34552042-D3EEB5DA-5F44-42EA-BDE2-48D4EEB46B02Q38670000-970DA123-831C-455D-833E-66A036F87D13Q38670250-208C743C-CDAE-46DE-9108-6612AD25EC26Q38679142-0BE69355-1AA9-4879-BBA0-AD4E1762810BQ39094276-E298B9F1-5034-40E0-A33D-71DDDD705F2CQ39200135-9D0A8F04-21AA-4ADD-9439-F2C61D42DF0DQ42318005-A3BD9F31-0F59-4A35-8611-292405001C10Q42503619-90C81D1C-A23D-4D9B-8641-9D3946D9C683Q46037449-F01C46D4-E907-4872-B69A-A1096D59CD1AQ46667195-A9A93047-6914-431C-AA86-5C192D998BCFQ47235728-918E3E1B-5D25-4928-B35E-926C2A00BF4CQ47580461-FE707AA5-08E4-45D7-BFB6-8D7229909B7DQ48011531-952AAC16-B5A9-4F7F-922D-EF0DD64E1592Q48023007-A49408AC-2CFF-42A5-9A52-AAF7850F08D3Q50089322-F924DA54-7EA2-4853-9D1B-F8F257D49485Q52683991-68C2CFA9-3FE2-4BAF-ABC1-6F0A3618ACABQ55298059-C5FA0607-2E6C-4F41-8F7E-CAF91A54D05E
P2860
Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted detection of genetic ...... in paediatric thalamic glioma.
@en
Targeted detection of genetic ...... in paediatric thalamic glioma.
@nl
type
label
Targeted detection of genetic ...... in paediatric thalamic glioma.
@en
Targeted detection of genetic ...... in paediatric thalamic glioma.
@nl
prefLabel
Targeted detection of genetic ...... in paediatric thalamic glioma.
@en
Targeted detection of genetic ...... in paediatric thalamic glioma.
@nl
P2093
P2860
P50
P1476
Targeted detection of genetic ...... in paediatric thalamic glioma.
@en
P2093
Anthony Arnoldo
Joshua B Rubin
Matthew Mistry
Pawel Buczkowicz
Rahul Krishnatry
Robert Siddaway
Sanja Pajovic
Scott Ryall
P2860
P2888
P356
10.1186/S40478-016-0353-0
P577
2016-08-31T00:00:00Z